Clinical Trials Browser

Phase 1 × darolutamide × 30 days × Clear all

Advanced Solid Tumor

NCT05818683 2026-04-13

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Phase 1 Recruiting

300 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Neoplasms

NCT07103018 2026-03-23

STRIKE-001

Phase 1 Recruiting

144 enrolled

Genitourinary

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Clinical Trials

SNV1521 in Participants With Advanced Solid Tumors

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

STRIKE-001